Keywords: sales, rise, acquisitions, galen, underlying, growth, solid
Sales rise on acquisitions at Galen; underlying growth solid in second quarter
Article | 18 August 2003
Northern Ireland-headquartered Galen Holdings has outperformed the expectations of many analysts in the fiscal third quarter ended June 30, 2003, posting a 73% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
